The mouse models of human BC also indicate that the stimulation of the cyclin D1–CDK4/6 axis leads to a tumorigenic phenotype and contributes toward the initiation and maintenance of tumorigenesis in HER2+ BC [101]. Here, CDK4 is linked to breast cancer.